MEDICLIN continues to show stable business performance

MEDICLIN reports a solid first half of 2026

MEDICLIN AG: Annual General Meeting approves all proposed resolutions

MEDICLIN increases group operating result in the first quarter

MEDICLIN lays a solid foundation for further growth with its 2025 financial results

Dr. Joachim Ramming verlässt den Vorstand der MEDICLIN AG zum Ende des Geschäftsjahres 2025

MEDICLIN on track: business development in line with expectations

MEDICLIN reports positive interim results for the first half of 2025

MEDICLIN AG: Annual General Meeting approves all proposed resolutions

MEDICLIN increases group operating result in the first quarter of 2025